Skip Navigation

VAERS Bibliography - November 2002

  1. Pneumococcal Vaccination for Cochlear Implant Recipients.  MMWR Morb.Mortal.Wkly.Rep.  10-18-2002, 51 (41): 931.

  2. Vaccination Mondiale Et Terreur Mondiale.  CMAJ.  10-15-2002, 167 (8): 839.

  3. Global Vaccination Meets Global Terror.  CMAJ.  10-15-2002, 167 (8): 837, 839.

  4. From the Centers for Disease Control and Prevention. National, State, and Urban Area Vaccination Levels Among Children Aged 19-35 Months--United States, 2001.  JAMA  10-9-2002, 288 (14): 1713-1714.

  5. VI.7 Vaccine Recommendations for Patients on Chronic HD (Except HB Vaccination).  Nephrol.Dial.Transplant.  2002, 17 Suppl 7:81-87.

  6. Progress in Polio Eradication: Vaccine Strategies for the End Game. Paris, France, 28-30 June 2000. Proceedings.  Dev.Biol.(Basel)  2001, 105:1-244.

  7. Hazards of Immunisation.  Lancet  10-21-1967, 2 (7521): 888-889.

  8. Abbey, D. M.  Antivaccination Web Sites.  JAMA  10-9-2002, 288 (14): 1717.

  9. Ahmed, F., Elbasha, E. E., Thompson, B. L., Harris, J. R., and Sneller, V. P.  Cost-Benefit Analysis of a New HEDIS Performance Measure for Pneumococcal Vaccination.  Med.Decis.Making  2002, 22 (5 Suppl): S58-S66. 

  10. Arita, I.  Duration of Immunity After Smallpox Vaccination: A Study on Vaccination Policy Against Smallpox Bioterrorism in Japan.  Jpn.J Infect.Dis.  2002, 55 (4): 112-116.

  11. Batayneh, N. and Bdour, S.  Mumps: Immune Status of Adults and Epidemiology As a Necessary Background for Choice of Vaccination Strategy in Jordan.  APMIS  2002, 110 (7-8): 528-534.

  12. Birchmeier, M., Favrat, B., Pecoud, A., Abetel, G., Karly, M., Landry, P., Mancini, M., Verdon, F., and Genton, B.  Improving Influenza Vaccination Rates in the Elderly.  J Fam.Pract.  2002, 51 (10): 856. 

  13. Borrow, R., Goldblatt, D., Andrews, N., Southern, J., Ashton, L., Deane, S., Morris, R., Cartwright, K., and Miller, E.  Antibody Persistence and Immunological Memory at Age 4 Years After Meningococcal Group C Conjugate Vaccination in Children in the United Kingdom.  J Infect.Dis.  11-1-2002, 186 (9): 1353-1357. 

  14. Bunout, D., Hirsch, S., Pia, de la Maza, Munoz, C., Haschke, F., Steenhout, P., Klassen, P., Barrera, G., Gattas, V., and Petermann, M.  Effects of Prebiotics on the Immune Response to Vaccination in the Elderly.  JPEN J Parenter.Enteral Nutr.  2002, 26 (6): 372-376. 

  15. Charatan, F.  US Health Officials Recommend Offering Smallpox Vaccination to All.  BMJ  10-12-2002, 325 (7368): 794.

  16. Davies, P.  Antivaccination Web Sites.  JAMA  10-9-2002, 288 (14): 1717.

  17. Graham-Rowe, D. and MacKenzie, D.  Tough Choices: Would a Separate Measles Vaccination Be a Disaster for Britain?.  New Sci.  2-16-2002, 173 (2330): 12-13.

  18. Greene, A.  Vaccination Fears: What the School Nurse Can Do.  J Sch Nurs.  2002, Suppl:31-5. (): 31-35.

  19. Gurfinkel, E. and Mautner, B.  Secondary Prevention of Coronary Artery Disease. Flu Vaccinations and New Evidence of the Role of Infection in Acute Coronary Syndromes.  Rev.Esp.Cardiol.  2002, 55 (10): 1009-1012. 

  20. Hasanain, F. H. and Jan, M. M.  Delays in Primary Vaccination of Infants Living in Western Saudi Arabia.  Saudi.Med.J  2002, 23 (9): 1087-1089.

  21. Jonsson, S., Vidarsson, G., Valdimarsson, H., Schiffman, G., Schneerson, R., and Jonsdottir, I.  Vaccination of COPD Patients With a Pneumococcus Type 6B Tetanus Toxoid Conjugate Vaccine.  Eur.Respir.J  2002, 20 (4): 813-818.
     
  22. Levitsky, J., Te, H. S., Faust, T. W., and Cohen, S. M.  Varicella Infection Following Varicella Vaccination in a Liver Transplant Recipient.  Am.J Transplant.  2002, 2 (9): 880-882. 

  23. Makela, A., Nuorti, J. P., and Peltola, H.  Neurologic Disorders After Measles-Mumps-Rubella Vaccination.  Pediatrics  2002, 110 (5): 957-963. 

  24. Manuel, D. G., Henry, B., Hockin, J., and Naus, M.  Health Behavior Associated With Influenza Vaccination Among Healthcare Workers in Long-Term-Care Facilities.  Infect.Control Hosp.Epidemiol.  2002, 23 (10): 609-614.

  25. Mayor, S.  Chief Medical Officer Confirms Key Health Workers Will Be Vaccinated Against Smallpox.  BMJ  2002, 19; 325 (7369): 855B.

  26. Rangel, M. C., Schoenbach, V., Hogan, V., and Weigle, K.  #72-S Racial/Ethnic Disparities in Influenza Vaccination in Elderly Adults. The Role of Access to Care.  Ann.Epidemiol.  2002, 12 (7): 516. 

  27. Mostowy, S. and Behr, M. A.  Comparative Genomics in the Fight Against Tuberculosis: Diagnostics, Epidemiology, and BCG Vaccination.  Am.J Pharmacogenomics.  2002, 2 (3): 189-196. 

  28. Nakatani, H., Sano, T., and Iuchi, T.  Development of Vaccination Policy in Japan: Current Issues and Policy Directions.  Jpn.J Infect.Dis.  2002, 55 (4): 101-111. 

  29. Nasir, L.  Antivaccination Web Sites.  JAMA  10-9-2002, 288 (14): 1718.

  30. Neff, J. M., Lane, J. M., Fulginiti, V. A., and Henderson, D. A.  Contact Vaccinia--Transmission of Vaccinia From Smallpox Vaccination.  JAMA  10-16-2002, 288 (15): 1901-1905.

  31. Ogunbanjo, G. A., Durrheim, D. N., Gouws, A., and Grobler, S.  Intradermal BCG Vaccination--Limiting Local Adverse Reactions.  S Afr.Med.J  2002, 92 (9): 665-666.

  32. Pasinetti, G. M., Ho, L., and Pompl, P.  AN1792 Vaccination Immunotherapy in Alzheimer's Disease: the Case of a Therapy Before Its Time.  Neurobiol.Aging  2002, 23 (5): 683.

  33. Plans, P.  [Cost-Effectiveness of 23-Valent Antipneumococcical Vaccination in Catalonia, Spain].  Gac.Sanit.  2002, 16 (5): 392-400. 

  34. Portaels, F., Aguiar, J., Debacker, M., Steunou, C., Zinsou, C., Guedenon, A., and Meyers, W. M.  Prophylactic Effect of Mycobacterium Bovis BCG Vaccination Against Osteomyelitis in Children With Mycobacterium Ulcerans Disease (Buruli Ulcer).  Clin.Diagn.Lab Immunol.  2002, 9 (6): 1389-1391. 

  35. Rush, C., Mitchell, T., and Garside, P.  Efficient Priming of CD4(+) and CD8(+) T Cells by DNA Vaccination Depends on Appropriate Targeting of Sufficient Levels of Immunologically Relevant Antigen to Appropriate Processing Pathways.  J Immunol.  11-1-2002, 169 (9): 4951-4960. 

  36. Schlafly, R.  Antivaccination Web Sites.  JAMA  10-9-2002, 288 (14): 1717.

  37. Sibley, C. L.  Smallpox Vaccination Revisited.  Am.J Nurs.  2002, 102 (9): 26-32. 

  38. Steiner, M., Vermeulen, L. C., Mullahy, J., and Hayney, M. S.  Factors Influencing Decisions Regarding Influenza Vaccination and Treatment: a Survey of Healthcare Workers.  Infect.Control Hosp.Epidemiol.  2002, 23 (10): 625-627. 

  39. Tan, H. H. and Seow, C. S.  A Review of Cutaneous Granulomas and Lupus Vulgaris Following BCG Vaccination in a Skin Hospital in Singapore.  Ann.Acad.Med.Singapore  2002, 31 (5): 663-665. 

  40. Tarjan, P., Sipka, S., Marodi, L., Nemes, E., Lakos, G., Gyimesi, E., Kiss, E., Ujj, G., and Szegedi, G.  No Short-Term Immunological Effects of Pneumococcus Vaccination in Patients With Systemic Lupus Erythematosus.  Scand.J Rheumatol.  2002, 31 (4): 211-215. 

  41. Tom, B., Moutou, F., Dufour, B., and Durand, B.  Ring Vaccination Against Foot-and-Mouth Disease.  Comp Immunol.Microbiol.Infect.Dis.  2002, 25 (5-6): 365-372. 

  42. Wang, L., Smith, D., Bot, S., Dellamary, L., Bloom, A., and Bot, A.  Noncoding RNA Danger Motifs Bridge Innate and Adaptive Immunity and Are Potent Adjuvants for Vaccination.  J Clin.Invest  2002, 110 (8): 1175-1184. 

  43. Weightman, G. W.  Scientific Evidence Supports Anthrax Vaccination.  Am.J Public Health  2002, 92 (11): 1707-1708.

  44. Wutzler, P., Neiss, A., Banz, K., Goertz, A., and Bisanz, H.  Can Varicella Be Eliminated by Vaccination? Potential Clinical and Economic Effects of Universal Childhood Varicella Immunisation in Germany.  Med.Microbiol.Immunol.(Berl)  2002, 191 (2): 89-96. 

[top]